Upgrade to SI Premium - Free Trial

Fulcrum Therapeutics Inc. (FULC)

3.76 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/5/26)

Latest Headlines

Form 4 Fulcrum Therapeutics, For: Jul 16 Filed by: TANG KEVIN July 20, 2026 9:10 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: BlackRock Portfolio Management LLC July 17, 2026 11:34 AM - SEC Filing Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC July 15, 2026 7:54 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jul 13 Filed by: TANG KEVIN July 15, 2026 7:50 PM - SEC Filing Form 3 Fulcrum Therapeutics, For: Jul 13 Filed by: TANG KEVIN July 15, 2026 7:49 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Banks Sonja July 2, 2026 4:32 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Dorton Katina July 2, 2026 4:31 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Gould Robert J July 2, 2026 4:31 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Haviland Kate July 2, 2026 4:31 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: GERAGHTY JAMES A July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Ezekowitz Alan July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: King Rachel K. July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 30 Filed by: Hill Colin July 2, 2026 4:30 PM - SEC Filing Form 4 Fulcrum Therapeutics, For: Jun 26 Filed by: Ezekowitz Alan June 30, 2026 4:30 PM - SEC Filing Form 144 Fulcrum Therapeutics, Filed by: Ezekowitz Alan June 26, 2026 4:27 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: EcoR1 Capital, LLC June 25, 2026 6:11 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: EcoR1 Capital, LLC June 25, 2026 5:51 PM - SEC Filing Form 8-K Fulcrum Therapeutics, For: Jun 24 June 25, 2026 4:32 PM - SEC Filing Form 8-K Fulcrum Therapeutics, For: Jun 05 June 11, 2026 4:30 PM - SEC Filing Form SCHEDULE 13G Fulcrum Therapeutics, Filed by: TANG CAPITAL MANAGEMENT LLC June 10, 2026 6:13 PM - SEC Filing Form 8-K Fulcrum Therapeutics, For: May 31 June 4, 2026 4:05 PM - SEC Filing Goldman Sachs Drop Coverage of Fulcrum Therapeutics Inc. (FULC) June 2, 2026 4:26 PM - StreetInsider JPMorgan Double Downgrades Fulcrum Therapeutics (FULC) to Underweight June 2, 2026 4:26 PM - StreetInsider Fulcrum plummets over 50% after scrapping lead sickle-cell drug on FDA concerns June 2, 2026 6:42 AM - StreetInsider H.C. Wainwright Downgrades Fulcrum Therapeutics (FULC) to Neutral June 2, 2026 6:07 AM - StreetInsider Leerink Downgrades Fulcrum Therapeutics (FULC) to Market Perform June 2, 2026 6:03 AM - StreetInsider Piper Sandler Double Downgrades Fulcrum Therapeutics (FULC) to Underweight June 2, 2026 1:08 AM - StreetInsider Truist Securities Downgrades Fulcrum Therapeutics (FULC) to Hold June 2, 2026 1:04 AM - StreetInsider Stifel Downgrades Fulcrum Therapeutics (FULC) to Hold June 1, 2026 6:37 PM - StreetInsider After-Hours Stock Movers: HPE, CRDO, FULC, ABVX, MCHP June 1, 2026 4:37 PM - StreetInsider Fulcrum Therapeutics discontinues pociredir program, begins strategic review June 1, 2026 4:10 PM - StreetInsider Form 8-K Fulcrum Therapeutics, For: Jun 01 June 1, 2026 4:07 PM - SEC Filing Fulcrum Therapeutics Announces Discontinuation of Pociredir Program in Sickle Cell Disease and Initiation of Strategic Review June 1, 2026 4:05 PM - StreetInsider Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: Nantahala Capital Management, LLC May 15, 2026 4:43 PM - SEC Filing Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: TCG Crossover GP II, LLC May 15, 2026 4:33 PM - SEC Filing Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 8, 2026 4:30 PM - StreetInsider Form 4 Fulcrum Therapeutics, For: Apr 23 Filed by: Lehrer-Graiwer Joshua May 1, 2026 4:16 PM - SEC Filing Form 3 Fulcrum Therapeutics, For: Apr 23 Filed by: Lehrer-Graiwer Joshua May 1, 2026 4:10 PM - SEC Filing Form DEFA14A Fulcrum Therapeutics, April 30, 2026 4:20 PM - SEC Filing Form ARS Fulcrum Therapeutics, For: Dec 31 April 30, 2026 4:17 PM - SEC Filing Form DEF 14A Fulcrum Therapeutics, For: Jun 24 April 30, 2026 4:12 PM - SEC Filing Form 10-Q Fulcrum Therapeutics, For: Mar 31 April 27, 2026 7:11 AM - SEC Filing Fulcrum Therapeutics Inc. (FULC) Tops Q1 EPS by 5c April 27, 2026 7:07 AM - StreetInsider Form 8-K Fulcrum Therapeutics, For: Apr 23 April 27, 2026 7:05 AM - SEC Filing Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026 April 27, 2026 7:00 AM - Globe NewsWire Fulcrum Therapeutics adds Josh Lehrer to board of directors April 27, 2026 6:55 AM - StreetInsider Fulcrum Therapeutics Appoints Josh Lehrer to its Board of Directors April 27, 2026 6:55 AM - Globe NewsWire Full Article List